Boston, MA 10/13/2014 (wallstreetpr) – The share price of Hazmat-suit maker Lakeland Industries, Inc. (NASDAQ:LAKE) continued to gain on 10th October, even as global fear about the dreaded Ebola virus spreading to newer geographies continued to rise. During last week’s trading, the stock price of this RONKONKOMA, NY based safety garments and protective clothing maker has more than doubled to post 125 percent increase. The extended interest of the investor community in the stock of Lakeland Industries, Inc. (NASDAQ:LAKE) received renewed push after the first death due to Ebola infection was reported from U.S last week. Spain is also tracking the recovery of a one of its nurses who was infected in course of her profession. News reports which are yet to be officially confirmed have indicated that Brazil is treating a patient suspected to be down with Ebola. These wide spread fears are driving investors to buy into the Hazmat-suit maker stocks.
Disposable Protective Apparel maker Alpha Pro Tech, Ltd. (NYSEMKT:APT) saw its share price jump up by nearly 53 percent during trading on 10th October after the first death caused due to Ebola was reported from U.S last week. Globally the death toll due to the dreaded Ebola virus has cross the 4000 mark. The disease caused due to the Ebola virus, still does not have an approved drug treatment course. Hence global fight against this disease is concentrated on containment, which requires health care givers to be fully protected against accidental contamination from the patients they are treating by using the Hazmat-suits.
EXACT Sciences Corporation (NASDAQ:EXAS) share price rose nearly 35 percent during trading on 10th October after the firm announced that its flag ship “colon cancer test Cologuard” has been approved to be covered under medical insurance cover provided by Medicare. While the firm is yet to announce the price of this test under insurance cover, the “coverage determination” will go into effect with immediate effect.
Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. While reading this article one must assume that we may be compensated for posting this content on our website.